Recent successes of several FDA-approved therapeutic nucleic acids, together with the rapid preclinical progression of nucleic acid nanoparticles (NANPs), have made it apparent that immunological effects of NANPs must be carefully assessed to permit their successful clinical translation. Based on extensive studies, a standardized protocol allowing for the assessment of NANPs' pro-inflammatory properties in validated preclinical model, peripheral blood mononuclear cells, has been developed to be highly predictive of cytokine responses.
from Top Technology News -- ScienceDaily https://ift.tt/34sotGF
Monday, 26 October 2020
New test method to standardize immunological evaluation of nucleic acid nanoparticles
About Unknown
Magazine Power Theme is officially developed by Templatezy Team. We published High quality Blogger Templates with Awesome Design for blogspot lovers.The very first Blogger Templates Company where you will find Responsive Design Templates.
Subscribe to:
Post Comments (Atom)
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean. 
SOCIALIZE IT →